Duogynon: Analysis of a retrospective case series does not show a causal association with birth defects, but it can also not be ruled out with certainty
2012.09.05
Active substance:
The analytical results of a retrospective series of case-control studies yielding information on several types of birth defects in newborn babies in connection with the use of Duogynon during early pregnancy are now available to the BfArM.
risk information - full text (available in German only)